ro 31-7549 has been researched along with thromboxane b2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murphy, CT; Westwick, J | 1 |
| Hashimoto, N; Hashimoto, Y; Kurokawa, K; Nakahara, K; Sato, H; Togo, M; Watanabe, T | 1 |
2 other study(ies) available for ro 31-7549 and thromboxane b2
| Article | Year |
|---|---|
Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses.
Topics: Animals; Blood Platelets; Calcium; Enzyme Activation; Indoles; Kinetics; Maleimides; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Rabbits; Serotonin; Signal Transduction; Tetradecanoylphorbol Acetate; Thromboxane B2 | 1992 |
Characteristics of protein kinase C-independent exocytosis in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Triphosphate; Aspirin; Blood Platelets; Exocytosis; Humans; Indoles; Maleimides; Molecular Weight; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Thromboxane B2; Vasoconstrictor Agents | 1997 |